Capital Research Global Investors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,244,300
| Closed | -$20.7M | – | 435 |
|
|
2016
Q4 | $20.7M | Sell |
1,244,300
-3,179,058
| -72% | -$53M | 0.01% | 385 |
|
|
2016
Q3 | $91M | Sell |
4,423,358
-3,058,777
| -41% | -$62.9M | 0.03% | 280 |
|
|
2016
Q2 | $229M | Sell |
7,482,135
-1,138,704
| -13% | -$34.8M | 0.08% | 209 |
|
|
2016
Q1 | $323M | Sell |
8,620,839
-252,193
| -3% | -$9.44M | 0.11% | 173 |
|
|
2015
Q4 | $383M | Sell |
8,873,032
-67,670
| -0.8% | -$2.92M | 0.13% | 157 |
|
|
2015
Q3 | $335M | Hold |
8,940,702
| – | – | 0.12% | 169 |
|
|
2015
Q2 | $304M | Hold |
8,940,702
| – | – | 0.1% | 204 |
|
|
2015
Q1 | $317M | Hold |
8,940,702
| – | – | 0.11% | 193 |
|
|
2014
Q4 | $305M | Buy |
8,940,702
+7,268
| +0.1% | +$248K | 0.1% | 199 |
|
|
2014
Q3 | $345M | Buy |
8,933,434
+215,825
| +2% | +$8.32M | 0.12% | 175 |
|
|
2014
Q2 | $339M | Buy |
8,717,609
+288,251
| +3% | +$11.2M | 0.12% | 170 |
|
|
2014
Q1 | $288M | Buy |
8,429,358
+804,473
| +11% | +$27.5M | 0.1% | 186 |
|
|
2013
Q4 | $160M | Buy |
7,624,885
+1,888,185
| +33% | +$39.6M | 0.06% | 235 |
|
|
2013
Q3 | $135M | Buy |
5,736,700
+3,035,800
| +112% | +$71.3M | 0.05% | 246 |
|
|
2013
Q2 | $72.6M | Buy |
+2,700,900
| New | +$72.6M | 0.03% | 289 |
|